The safety and efficacy of transcranial direct current stimulation for daytime insomnia in adults with shift disorder: a randomized, double-blind, placebo-controlled parallel clinical trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051433

Enrollment

Unknown

Registered

2021-09-23

Start date

2021-09-20

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Experimental group:10 minutes of continuous electrical stimulation

Control group:no current stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 50 years; 2. Consent to contraception during the study (for female patients aged 18-50); 3. Agree not to receive drugs or other non-drug treatments throughout the trial period; 4. Sign informed consent; 5. Not participating in other clinical trials.

Exclusion criteria

Exclusion criteria: 1. Physical diseases such as severe heart, liver, and renal insufficiency; 2. Previously diagnosed epilepsy or had a history of epilepsy; 3. There are comorbidities of serious mental diseases such as schizophrenia; 4. Those who have attempted suicide or self-harm; 5. There are cochlear implants, pacemakers, implanted devices (such as deep brain stimulation DBS) or metal implants in the skull; 6. Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
Subjective sleepiness of subjects;	—

Countries

China

Contacts

Public ContactSu Changjun

The Second Affiliated Hospital of Air Force Military Medical University

changjunsu@163.com+86 13991387536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026